Lipoproteins in inflammation and sepsis. I. Basic science.
Intensive Care Med
; 33(1): 13-24, 2007 Jan.
Article
en En
| MEDLINE
| ID: mdl-17093985
ABSTRACT
BACKGROUND:
High-density lipoproteins (HDL) have been shown to bind and neutralize lipopolysaccharide (LPS) and are regarded as possible therapeutic agents for sepsis and conditions associated with local or systemic inflammation. However, in recent years, a multitude of possible immunomodulatory properties other than LPS neutralization have become evident.DISCUSSION:
This review highlights the advances in the understanding of how HDL is protective in both in vitro and in vivo inflammatory settings, including the ability of HDL to modulate adhesion molecule expression, upregulate endothelial nitric oxide synthase and counteract oxidative stress. Also, the active components of HDL and the recent discovery of novel lipid modulators of inflammation are discussed.
Buscar en Google
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Sepsis
/
Inflamación
/
Lipoproteínas HDL
Límite:
Animals
/
Humans
Idioma:
En
Revista:
Intensive Care Med
Año:
2007
Tipo del documento:
Article
País de afiliación:
Reino Unido